Clinical Effect of Somatostatin Analogue (Sandostatin) in Three Cases of Non-Malignant Enteropancreatic Disorders
We report three cases of different non-malignant gastrointestinal disorders in which long acting somatostatin analogue (Sandostatin) was successfully used.
Case 1
A 39-year-old male
Source: Annals of Saudi Medicine - Category: Journals (General) Tags: ISSUE 1 Source Type: research
More News: Cancer & Oncology | Gastroenterology | General Medicine | Middle East Health | Sandostatin